Clinically, people with PD carrying heterozygous GBA1 mutations (GBA1-PD) show more severe trajectories with faster progression of motor and non-motor impairment4,5, specifically more rapid and earlier development of cognitive decline6–8 compared to PD without GBA1 mutation. This evidence concerns the gene GBA1 and Parkinson disease.